Health & BeautyNews

Bridgepoint to acquire RoC Skincare

The strategic investment in RoC builds on the firm’s growing track record of supporting businesses in the wider dermatology ecosystem, including HTL, a leading producer of high-quality hyaluronic acid, and Vivacy, a global personal healthcare company

Bridgepoint has announced a strategic investment in RoC Skincare (RoC) from the brand’s existing backer, Gryphon Investors for an undisclosed amount.

Check out our free weekly podcast

Back to top button